Home/Cugene/Roger Mulholland, PhD
RM

Roger Mulholland, PhD

Founder and CEO

Cugene

Cugene Pipeline

DrugIndicationPhase
CUG252Autoimmune and Inflammatory DiseasesPre-clinical
TILKine™ PlatformSolid TumorsPre-clinical
VitoKine™ PlatformSolid TumorsPre-clinical